208 related articles for article (PubMed ID: 24471670)
1. The dosing and monitoring of argatroban for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a word of caution.
Phillips MR; Khoury AI; Ashton RF; Cairns BA; Charles AG
Anaesth Intensive Care; 2014 Jan; 42(1):97-8. PubMed ID: 24471670
[TBL] [Abstract][Full Text] [Related]
2. Argatroban in adult extracorporeal membrane oxygenation.
Johnston N; Wait M; Huber L
J Extra Corpor Technol; 2002 Dec; 34(4):281-4. PubMed ID: 12533066
[TBL] [Abstract][Full Text] [Related]
3. Argatroban for Heparin-Induced Thrombocytopenia during Venovenous Extracorporeal Membrane Oxygenation with Continuous Venovenous Hemofiltration.
Sin JH; Lopez ND
J Extra Corpor Technol; 2017 Jun; 49(2):115-120. PubMed ID: 28638161
[TBL] [Abstract][Full Text] [Related]
4. Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.
Yarbrough PM; Varedi A; Walker A; Rondina MT
Ann Pharmacother; 2012 Nov; 46(11):e30. PubMed ID: 23073302
[TBL] [Abstract][Full Text] [Related]
5. Use of argatroban for extracorporeal life support in patients with nonheparin-induced thrombocytopenia: Analysis of 10 consecutive patients.
Kim YS; Lee H; Yang JH; Sung K; Suh GY; Chung CR; Yang JH; Cho YH
Medicine (Baltimore); 2018 Nov; 97(47):e13235. PubMed ID: 30461625
[TBL] [Abstract][Full Text] [Related]
6. Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.
Fisser C; Winkler M; Malfertheiner MV; Philipp A; Foltan M; Lunz D; Zeman F; Maier LS; Lubnow M; Müller T
Crit Care; 2021 Apr; 25(1):160. PubMed ID: 33910609
[TBL] [Abstract][Full Text] [Related]
7. Argatroban Anticoagulation for Adult Extracorporeal Membrane Oxygenation: A Systematic Review.
Geli J; Capoccia M; Maybauer DM; Maybauer MO
J Intensive Care Med; 2022 Apr; 37(4):459-471. PubMed ID: 33653194
[TBL] [Abstract][Full Text] [Related]
8. Alternative anticoagulation during cardiovascular procedures in pediatric patients with heparin-induced thrombocytopenia.
Argueta-Morales IR; Olsen MC; DeCampli WM; Munro HM; Felix DE
J Extra Corpor Technol; 2012 Jun; 44(2):69-74. PubMed ID: 22893986
[TBL] [Abstract][Full Text] [Related]
9. Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation.
Matsuo T; Koide M; Kario K
Artif Organs; 1997 Sep; 21(9):1035-8. PubMed ID: 9288875
[TBL] [Abstract][Full Text] [Related]
10. Argatroban in the management of heparin-induced thrombocytopenia.
Babuin L; Pengo V
Vasc Health Risk Manag; 2010 Sep; 6():813-9. PubMed ID: 20859550
[TBL] [Abstract][Full Text] [Related]
11. Lung transplantation using argatroban in severe heparin-induced thrombocytopenia during extracorporeal membrane oxygenation: a case series.
Lee SK; Cho WH; Kim DH; Yeo HJ
Gen Thorac Cardiovasc Surg; 2020 Dec; 68(12):1565-1568. PubMed ID: 32266702
[TBL] [Abstract][Full Text] [Related]
12. Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban.
Scott LK; Grier LR; Conrad SA
Pediatr Crit Care Med; 2006 May; 7(3):255-7. PubMed ID: 16474254
[TBL] [Abstract][Full Text] [Related]
13. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
Saugel B; Phillip V; Moessmer G; Schmid RM; Huber W
Crit Care; 2010; 14(3):R90. PubMed ID: 20487559
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation with direct thrombin inhibitors during extracorporeal membrane oxygenation.
Burstein B; Wieruszewski PM; Zhao YJ; Smischney N
World J Crit Care Med; 2019 Oct; 8(6):87-98. PubMed ID: 31750086
[TBL] [Abstract][Full Text] [Related]
15. Argatroban in extracorporeal membrane oxygenation.
Beiderlinden M; Treschan T; Görlinger K; Peters J
Artif Organs; 2007 Jun; 31(6):461-5. PubMed ID: 17537058
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal membrane oxygenation bridging to lung transplant complicated by heparin-induced thrombocytopenia.
Dolch ME; Frey L; Hatz R; Uberfuhr PA; Beiras-Fernandez A; Behr J; Irlbeck M; Lung Transplant Group TM
Exp Clin Transplant; 2010 Dec; 8(4):329-32. PubMed ID: 21143102
[TBL] [Abstract][Full Text] [Related]
17. Argatroban use during pediatric interventional cardiac catheterization.
Cetta F; Graham LC; Wrona LL; Arruda MJ; Walenga JM
Catheter Cardiovasc Interv; 2004 Jan; 61(1):147-9. PubMed ID: 14696176
[TBL] [Abstract][Full Text] [Related]
18. Treatment options for heparin-induced thrombocytopenia.
Greinacher A
Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
[TBL] [Abstract][Full Text] [Related]
19. Role of argatroban during neurointerventional procedures in patients with heparin induced thrombocytopenia.
Alaraj A; Tobin M; Birk D; Aletich V
J Neurointerv Surg; 2014 Oct; 6(8):630-2. PubMed ID: 24062254
[TBL] [Abstract][Full Text] [Related]
20. [Intraoperative management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].
Ohno H; Yokoi M
Masui; 2002 Jan; 51(1):30-3. PubMed ID: 11840659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
